InvestorsHub Logo
Followers 827
Posts 119503
Boards Moderated 15
Alias Born 09/05/2002

Re: DewDiligence post# 38

Tuesday, 06/21/2022 2:03:19 PM

Tuesday, June 21, 2022 2:03:19 PM

Post# of 69
ASMB announces small-molecule IFN-receptor candidate for HBV program:

https://finance.yahoo.com/news/assembly-biosciences-introduce-small-molecule-120000640.html

Assembly Biosciences…plans to host a webcast on Tuesday, July 26, 2022 from 1:30-2:30 pm PT/4:30-5:30 pm ET to introduce its new research program advancing a novel, small molecule interferon-alpha receptor (IFNAR) agonist designed to selectively activate the interferon-alpha pathway within the liver and offer the convenience of oral dosing.

As far as I know, no other HBV company is pursing this approach. I wonder why the webcast is scheduled for five weeks from now rather than sooner.

Please see #msg-167605073 and #msg-168960516 for related info.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ASMB News